Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons

被引:243
作者
Ungless, MA
Singh, V
Crowder, TL
Yaka, R
Ron, D
Bonci, A [1 ]
机构
[1] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94110 USA
[2] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94110 USA
[3] Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94110 USA
关键词
D O I
10.1016/S0896-6273(03)00461-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Stress increases addictive behaviors and is a common cause of relapse. Corticotropin-releasing factor (CRF) plays a key role in the modulation of drug taking by stress. However, the mechanism by which CRF modulates neuronal activity in circuits involved in drug addiction is poorly understood. Here we show that CRF induces a potentiation of NMDAR (N-methyl-D-aspartate receptor)-mediated synaptic transmission in dopamine neurons of the ventral tegmental area (VTA). This effect involves CRF receptor 2 (CRF-R2) and activation of the phospholipase C (PLC)-protein kinase C (PKC) pathway. We also find that this potentiation requires CRF binding protein (CRF-BP). Accordingly, CRF-like peptides, which do not bind the CRF-BP with high affinity, do not potentiate NMDARs. These results provide evidence of the first specific roles for CRF-R2 and CRF-BP in the modulation of neuronal activity and suggest that NMDARs in the VTA may be a target for both drugs of abuse and stress.
引用
收藏
页码:401 / 407
页数:7
相关论文
共 37 条
[1]   CORTICOTROPIN RELEASING-FACTOR DECREASES POSTBURST HYPERPOLARIZATIONS AND EXCITES HIPPOCAMPAL-NEURONS [J].
ALDENHOFF, JB ;
GRUOL, DL ;
RIVIER, J ;
VALE, W ;
SIGGINS, GR .
SCIENCE, 1983, 221 (4613) :875-877
[2]   Differential distribution of corticotropin-releasing hormone immunoreactive axons in monoaminergic nuclei of the human brainstem [J].
Austin, MC ;
Rhodes, JL ;
Lewis, DA .
NEUROPSYCHOPHARMACOLOGY, 1997, 17 (05) :326-341
[3]   DISPLACEMENT OF CORTICOTROPIN-RELEASING FACTOR FROM ITS BINDING-PROTEIN AS A POSSIBLE TREATMENT FOR ALZHEIMERS-DISEASE [J].
BEHAN, DP ;
HEINRICHS, SC ;
TRONCOSO, JC ;
LIU, XJ ;
KAWAS, CH ;
LING, N ;
DESOUZA, EB .
NATURE, 1995, 378 (6554) :284-287
[4]  
Blank T, 2002, J NEUROSCI, V22, P3788
[5]  
Bonci A, 1999, J NEUROSCI, V19, P3723
[6]   Paradoxical activational effects of a corticotropin-releasing factor-binding protein "ligand inhibitor" in rat brain [J].
Chan, RKW ;
Vale, WW ;
Sawchenko, PE .
NEUROSCIENCE, 2000, 101 (01) :115-129
[7]   THE TIME COURSE OF GLUTAMATE IN THE SYNAPTIC CLEFT [J].
CLEMENTS, JD ;
LESTER, RAJ ;
TONG, G ;
JAHR, CE ;
WESTBROOK, GL .
SCIENCE, 1992, 258 (5087) :1498-1501
[8]   The CRF peptide family and their receptors: yet more partners discovered [J].
Dautzenberg, FM ;
Hauger, RL .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (02) :71-77
[9]   CORTICOTROPIN-RELEASING FACTOR ADMINISTRATION ELICITS A STRESS-LIKE ACTIVATION OF CEREBRAL CATECHOLAMINERGIC SYSTEMS [J].
DUNN, AJ ;
BERRIDGE, CW .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 27 (04) :685-691
[10]  
Fitzgerald LW, 1996, J NEUROSCI, V16, P274